Anbio Biotechnology (NNNN) Enterprise Value (2023 - 2025)

Anbio Biotechnology (NNNN) has 3 years of Enterprise Value data on file, last reported at -$11.9 million in Q4 2025.

• On a quarterly basis, Enterprise Value fell 1.19% year-over-year to -$11.9 million in Q4 2025; TTM through Dec 2025 was -$11.9 million, a 1.19% decrease from a year earlier, with the FY2025 full-year figure at -$11.9 million, down 1.19% from the prior year.
• Enterprise Value for Q4 2025 stood at -$11.9 million, up from -$13429.0 billion in the prior quarter.
• Over the last five years, Enterprise Value for NNNN reached as high as -$9.7 million in Q4 2023 and fell as low as -$13429.0 billion in Q2 2025.
• Historically, Enterprise Value has averaged -$3357.3 billion across 3 years, with a median of -$11.8 million in 2024.
• Across the five-year window, Enterprise Value decreased 21.36% in 2024 and slipped 1.19% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$9.7 million in 2023, then dropped by 21.36% to -$11.8 million in 2024, then fell by 1.19% to -$11.9 million in 2025.
• Per Business Quant data, the three most recent Enterprise Value figures were -$11.9 million in Q4 2025, -$13429.0 billion in Q2 2025, and -$11.8 million in Q4 2024.